The umbilical cord blood banking market size is projected to reach US$ 7.8 billion by 2031 from US$ 3.4 billion in 2023. The market is expected to register a CAGR of 11.0% during 2023–2031. Increasing hybrid banking models is likely to remain a key trend in the market.

Umbilical Cord Blood Banking Market Analysis

Factors such as the increasing use of umbilical cord blood in genetic rare disease research and treatment propel the umbilical cord blood banking market growth. However, product recalls impede market growth.

Umbilical Cord Blood Banking Market Overview

The rising geriatric population and unhealthy lifestyle contribute to the increasing prevalence of chronic diseases, propelling the demand for alternative and potentially curative treatment options. Around 41,000 people are diagnosed with blood cancer annually, making it the sixth most frequent cancer in the UK, according to Blood Cancer UK. In the UK, there are roughly 250,000 persons who are suffering from blood cancer. At some time in their lives, one in every 16 men and one in every 22 women will develop it. It is the most prevalent type of cancer in children. More than 500 kids under the age of 15 receive a blood cancer diagnosis each year. Of them, roughly 400 have lymphoma, and about 100 have pediatric leukemia. The geriatric population is highly prone to blood cancer. People aged 75 years and above make up slightly under 40% of those diagnosed with the disease. Umbilical cord blood, rich in hematopoietic stem cells, offers a valuable option for treating various conditions, including blood cancers, autoimmune diseases, and genetic disorders. There are rising advancements in stem cell research and the increasing success rates of cord blood transplants in treating a more comprehensive range of diseases. The realization that a child's cord blood can provide a potentially life-saving resource for themselves or a family member is a powerful motivator for parents. Thus, families are increasingly opting to preserve their child's cord blood, recognizing its potential therapeutic value for future use in case of a medical need, particularly in the face of escalating chronic illness rates. Therefore, the growing need for stem cell-based therapies due to the rising prevalence of chronic illnesses fuels the umbilical cord blood banking market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Umbilical Cord Blood Banking Market: Strategic Insights

Umbilical Cord Blood Banking Market

• 
  CAGR (2023 - 2031)

  11.0%
• Market Size 2023
  US$ 3.4 Billion
• Market Size 2031
  US$ 7.8 Billion

Market Dynamics

GROWTH DRIVERS

• The growing need for stem cell-based therapies due to the rising prevalence of chronic illnesses fuels the umbilical cord blood banking market growth

FUTURE TRENDS

• Increasing technological advancements and rising demand for stem cell therapies, hybrid banking models are expected to emerge as a major trend in the umbilical cord blood banking market during the forecast period.

OPPORTUNITIES

• Rising government funding in cord blood banking is expected to create lucrative opportunities for the umbilical cord blood banking market in the coming years.

Key Players

• Cordlife India,
• Biocell,
• CryoStemcell,
• NovaCord,
• LifeCell,
• HÉMA-QUÉBEC,
• Atlantic Health System,
• WMDA,
• CryoViva Singapore,
• ViaCord, Inc

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Bank Type

• Public and Private

Service

• Storage and Processing

End User

• Hospitals
• Research Institutes
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Umbilical Cord Blood Banking Market Drivers and Opportunities

Evolving Field of Regenerative Medicine Favors Market

The burgeoning field of regenerative medicine focuses on repairing and regenerating damaged tissues and organs. As researchers unlock the immense potential of stem cells, particularly those found in umbilical cord blood, the demand for these cells is rapidly increasing. The evolving landscape of regenerative medicine is pushing the boundaries of what's possible in treating a wide array of diseases and conditions, from blood cancers and autoimmune disorders to neurological and orthopedic injuries. The promise of regenerative therapies using cord blood stem cells is attracting patients and medical professionals, who are increasingly recognizing the unique therapeutic advantages these cells offer. This expanding awareness, coupled with ongoing research and clinical trials demonstrating the efficacy of cord blood stem cell therapies, is driving a significant increase in the number of families opting to bank their child's cord blood. As regenerative medicine continues to evolve and demonstrate its therapeutic potential, the umbilical cord blood banking market experiences sustained growth driven by the increasing demand for these vital cells.

Rise in Government Funding to Create Market Opportunities

Governments across the world are recognizing the potential life-saving treatments that stem cells derived from umbilical cord blood can offer. This realization has led to enhanced support in the form of grants and subsidies aimed at public and private cord blood banks. The financial backing is instrumental in advancing research and development within the field, enabling the exploration of new therapeutic avenues for conditions that currently have limited treatment options. Moreover, the funding is facilitating the expansion of storage facilities, which is crucial for maintaining the viability of cord blood units over extended periods.

The rising investment is encouraging expectant parents, who are now more informed about the benefits of cord blood banking. This awareness, coupled with financial incentives, is likely to lead to an increase in the number of cord blood units being banked, thereby enriching the diversity and availability of stem cells for transplantation. The rise in government funding is catalyzing scientific progress and creating a more robust infrastructure for the umbilical cord blood banking market. This is also expected to open up new horizons in regenerative medicine and offer hope for many patients affected by challenging medical conditions.

Following is a list of a few key funding initiatives undertaken by governments and organizations.

• In April 2023, Fifty community groups and organizations across England and Wales received US$ 745.30 in funding as part of the Government's commitment to continue to promote organ, blood, and stem cell donation among Black and Asian communities and tackle health inequalities.
• In 2023, Health Resources & Services Administration (HRSA) awarded a total of US$18.3 million to cord blood banks, and HRSA awarded a total of US$17.3 million in 2022.

Thus, rising government funding in cord blood banking is expected to create lucrative opportunities for the umbilical cord blood banking market in the coming years.

Umbilical Cord Blood Banking Market Report Segmentation Analysis

Key segments that contributed to the derivation of the umbilical cord blood banking market analysis are product type, application, end user.Based on bank type, the umbilical cord blood banking market is segmented into bifurcated into public and private. The private segment held a larger market share in 2023.

• By service, the market is segmented into storage and processing. The storage segment held a larger share of the market in 2023.
• Based on end user, the market is segmented into hospitals, research institutes, and others. The hospitals segment dominated the market in 2023.

Umbilical Cord Blood Banking Market Share Analysis by Geography

The geographic scope of the umbilical cord blood banking market report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America dominated the market in 2023. The North America umbilical cord blood banking market has been analyzed on the basis of the US, Canada, and Mexico. The market growth in this region is driven by the availability of a large number of public cord blood banking services, and governments providing support in the form of funding and favorable regulations.

Umbilical Cord Blood Banking Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Umbilical Cord Blood Banking Market News and Recent Developments

The umbilical cord blood banking market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the umbilical cord blood banking market are listed below:

• The US FDA announced approval of OMISIRGE’s expanded cord blood products intended for use in stem cell transplantation. The approval by the US FDA has the potential to transform the field of regenerative medicine, proving effective in patients aged 12 and above suffering from high-risk blood cancers and other hematological disorders [Source: OMISIRGE’s, Company Website, February 2023]

Umbilical Cord Blood Banking Market Report Coverage and Deliverables

The "Umbilical Cord Blood Banking Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• Transient protein expression market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Transient protein expression market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter's Five Forces and SWOT analysis
• Transient protein expression market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the umbilical cord blood banking market
• Detailed company profiles